TW200801075A - Dendritic polymers with enhanced amplification and interior functionality - Google Patents

Dendritic polymers with enhanced amplification and interior functionality

Info

Publication number
TW200801075A
TW200801075A TW095122332A TW95122332A TW200801075A TW 200801075 A TW200801075 A TW 200801075A TW 095122332 A TW095122332 A TW 095122332A TW 95122332 A TW95122332 A TW 95122332A TW 200801075 A TW200801075 A TW 200801075A
Authority
TW
Taiwan
Prior art keywords
dendritic
dendritic polymers
interior
reagents
functionality
Prior art date
Application number
TW095122332A
Other languages
English (en)
Other versions
TWI356709B (en
Inventor
Donald A Tomalia
Douglas R Swanson
Baohua Huang
Veera Reddy Pulgam
Original Assignee
Dendritic Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/013864 external-priority patent/WO2006065266A2/en
Application filed by Dendritic Nanotechnologies Inc filed Critical Dendritic Nanotechnologies Inc
Publication of TW200801075A publication Critical patent/TW200801075A/zh
Application granted granted Critical
Publication of TWI356709B publication Critical patent/TWI356709B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/005—Dendritic macromolecules
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0001—Post-treatment of organic pigments or dyes
    • C09B67/0004—Coated particulate pigments or dyes
    • C09B67/0008—Coated particulate pigments or dyes with organic coatings
    • C09B67/0013—Coated particulate pigments or dyes with organic coatings with polymeric coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Mathematical Physics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW095122332A 2005-04-20 2006-06-21 Dendritic polymers with enhanced amplification and TWI356709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/013864 WO2006065266A2 (en) 2004-04-20 2005-04-20 Dendritic polymers with enhanced amplification and interior functionality

Publications (2)

Publication Number Publication Date
TW200801075A true TW200801075A (en) 2008-01-01
TWI356709B TWI356709B (en) 2012-01-21

Family

ID=37215167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095122332A TWI356709B (en) 2005-04-20 2006-06-21 Dendritic polymers with enhanced amplification and

Country Status (6)

Country Link
EP (2) EP1877103A4 (zh)
JP (1) JP2008545621A (zh)
CA (1) CA2598430C (zh)
MX (1) MX2007010402A (zh)
TW (1) TWI356709B (zh)
WO (1) WO2006115547A2 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI557154B (zh) * 2015-07-02 2016-11-11 國立臺灣科技大學 超分子聚合物及其製作方法
CN113518757A (zh) * 2019-03-13 2021-10-19 伊士曼化工公司 可用于制造环十二硫的方法

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005317193A1 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality
EP1991277A4 (en) * 2006-03-03 2010-12-22 Dendritic Nanotechnologies Inc DELIVERY OF BIOLOGICALLY ACTIVE MATERIALS WITH CORE-SHELL TECTO (DENDRITEN POLYMERS)
DE102006036326A1 (de) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen
US20090324742A1 (en) * 2006-09-08 2009-12-31 Sonke Svenson Peham dendrimers as excipients
US7939095B2 (en) * 2006-12-21 2011-05-10 Cordis Corporation Crosslinked silane coating for medical devices
EP1958624A1 (en) * 2007-02-16 2008-08-20 Freie Universität Berlin Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
FR2925505B1 (fr) * 2007-12-24 2010-04-02 Arkema France Procede de preparation d'un materiau forme de molecules arborescentes comportant des groupes associatifs
US8071679B2 (en) * 2008-02-29 2011-12-06 Ppg Industries Ohio, Inc Coating compositions comprising a polymer containing an oligomeric macromonomer
JP5093680B2 (ja) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 ビス四級アンモニウム塩コア型デンドリマー
FR2935836B1 (fr) * 2008-09-08 2012-11-23 Commissariat Energie Atomique Nanocristaux semi-conducteurs
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
IT1393368B1 (it) * 2009-03-23 2012-04-20 Dipharma Francis Srl Metodo per la preparazione di rufinamide
AU2010234539B2 (en) 2009-04-07 2015-04-09 Corteva Agriscience Llc Nanoparticle mediated delivery of sequence specific nucleases
JP2011055751A (ja) * 2009-09-09 2011-03-24 Tokyo Univ Of Agriculture & Technology デンドリマー修飾磁気微粒子の製造方法
US8247151B2 (en) 2009-10-19 2012-08-21 Hewlett-Packard Development Company, L.P. Liquid toner, electrophoretic ink, and methods of making and use
BR112012009847B1 (pt) * 2009-10-26 2021-04-13 Dendritc Nanotechnologies, Inc. Formulação compreendendo dendrímeros peham para uso em agricultura, e método para tratamento de plantas ou sementes
US9296860B2 (en) 2009-12-21 2016-03-29 Dsm Assets B.V. Polymer, process and composition
EP2571525A4 (en) 2010-05-18 2016-04-27 Cerulean Pharma Inc Compositions and methods for treating autoimmune and other diseases
FR2961208B1 (fr) * 2010-06-09 2012-11-23 Oreal Poly 2-pyrrolidones fonctionnalisees par un radical ester, acide ou amide, composition cosmetique les comprenant et leur utilisation comme agent dispersant
US20120225129A1 (en) * 2010-08-20 2012-09-06 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
IT1402520B1 (it) * 2010-10-19 2013-09-13 Ivm Chemicals Srl Rivestimento non nocivo attivo contro i microorganismi
WO2012094620A2 (en) * 2011-01-09 2012-07-12 Anp Technologies, Inc. Hydrophobic molecule-induced branched polymer aggregates and their use
US9334351B2 (en) 2011-06-17 2016-05-10 Isp Investments Inc. 4- and 5-substituted 1,2,3-triazole, and regioisomer mixtures thereof, modified polymers
WO2012175622A1 (en) * 2011-06-21 2012-12-27 Dsm Ip Assets B.V. Polymer, process and use
US20140200333A1 (en) * 2011-08-15 2014-07-17 Seta Biomedicals, Llc Dendron reporter molecules
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
JP5920024B2 (ja) * 2012-05-25 2016-05-18 Dic株式会社 フッ素化脂肪族基を含むスルホニルアミド化合物の製造方法及びアニオン性親水基含有界面活性剤の製造方法
EP2861988B1 (en) 2012-06-14 2019-05-22 The Whitehead Institute for Biomedical Research Genome-wide method of assessing interactions between chemical entities and their target molecules
TWI524825B (zh) 2012-10-29 2016-03-01 財團法人工業技術研究院 碳材導電膜的轉印方法
WO2014136906A1 (ja) * 2013-03-06 2014-09-12 Ｊｘ日鉱日石エネルギー株式会社 摩擦調整剤および潤滑油組成物
CN105764491A (zh) * 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
EA036983B1 (ru) 2014-05-21 2021-01-22 АйСиДи-ТЕРАПЬЮТИКС ГМБХ Терапевтические конъюгаты с сульфатированными дендримерами для внутриклеточного нацеливания
CA2949868C (en) 2014-05-29 2022-07-26 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
CN115350285A (zh) 2014-08-13 2022-11-18 约翰霍普金斯大学 树枝状聚合物到脑肿瘤的选择性传递
US10968176B2 (en) 2014-09-14 2021-04-06 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
EP3194365A4 (en) * 2014-09-14 2018-04-25 Nanosynthons LLC Pyrrolidone derivatives, oligomers and polymers
WO2016046847A1 (en) 2014-09-23 2016-03-31 Council Of Scientific & Industrial Research Metal embedded hydrophilic polymer for drug delivery applications
CN104928919B (zh) * 2015-07-10 2017-03-08 广州大学 一种柔软协同抗菌刷型多季铵盐织物整理剂及其制备方法
EP3390348B1 (en) 2015-12-16 2024-04-17 Loveland Products, Inc. Dendrimer and formulations thereof
CA3061630C (en) 2017-04-27 2021-12-07 The Johns Hopkins University Dendrimer compositions for use in angiography
EP3707193A1 (en) 2017-11-10 2020-09-16 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
WO2020020714A1 (en) 2018-07-23 2020-01-30 Dsm Ip Assets B.V. Multi-aziridine compound
US10954346B2 (en) 2018-12-27 2021-03-23 Industrial Technology Research Institute Resin and ink
CN110694599A (zh) * 2019-09-26 2020-01-17 浙江海洋大学 一种聚丙烯亚胺修饰的磁性纳晶纤维素分子印迹聚合物的制备方法
EP4069308A2 (en) 2019-12-04 2022-10-12 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye
CN115038734A (zh) 2020-01-22 2022-09-09 科思创(荷兰)有限公司 多氮丙啶化合物
CN111440824B (zh) * 2020-05-26 2022-07-12 北京化工大学 一种基于乳糖通过氨基-环氧开环反应构建肝靶向阳离子基因载体及其制备方法
CN111848969A (zh) * 2020-07-27 2020-10-30 洛阳理工学院 一种超支化双功能星型化合物、聚合物电解质材料及制备与应用
CN113698549B (zh) * 2021-09-03 2024-05-14 上海昶法新材料有限公司 超支化聚合物及其制备方法、应用、洗涤产品
CN116023669B (zh) * 2021-10-27 2023-12-15 兰州大学 一种杂臂超分子星形共聚物、其制备方法与应用
CN114044907B (zh) * 2021-12-15 2022-11-11 兴宇汽车零部件股份有限公司 一种膨胀阻燃功能化poss阻燃剂及其制备方法
CN114606190A (zh) * 2022-03-08 2022-06-10 东南大学 用于细胞杀伤及出泡的纳米试剂、细胞微米囊泡及其制备方法和应用
CN114632194B (zh) * 2022-04-11 2023-05-23 东莞市人民医院 具有长效no催化释放的涂层材料及制备方法和应用
CN115044008B (zh) * 2022-06-01 2024-01-05 武汉中科先进材料科技有限公司 一种亲水型阳离子光固化树脂及其制备方法和应用
CN115057552B (zh) * 2022-06-23 2023-06-02 先导薄膜材料有限公司 一种低浓度硝酸铵废水浓缩方法
CN115678271B (zh) * 2022-11-02 2023-08-22 常州大学 一种生物基聚酰胺植物染料色母粒的制备方法
CN117946349A (zh) * 2024-03-26 2024-04-30 潍坊弘润新材料有限公司 一种树枝状聚合物改性羟基丙烯酸乳液、制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361337A (en) 1979-05-15 1982-11-30 Adriel Montes Piston ring with tongue and groove joint
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4631337A (en) 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
IL69558A (en) 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4740585A (en) 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5714166A (en) 1986-08-18 1998-02-03 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates
ES2054678T5 (es) * 1986-08-18 1997-09-16 Dow Chemical Co Conjugados estrella.
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US4735799A (en) 1987-01-14 1988-04-05 Patarroyo Manuel E Malaria vaccine
US5631329A (en) 1990-08-27 1997-05-20 Dendritech, Inc. Process for producing hyper-comb-branched polymers
US5773527A (en) 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
SE503342C2 (sv) * 1994-10-24 1996-05-28 Perstorp Ab Hyperförgrenad makromolekyl av polyestertyp samt förfarande för dess framställning
IT1277596B1 (it) * 1995-09-15 1997-11-11 Bracco Spa Composti macromolecolari di tipo dendrimerico
US5760142A (en) * 1996-12-04 1998-06-02 Dentsply Detrey G.M.B.H. Epoxide-amine dendrimers and the preparation and use thereof
FR2790642A1 (fr) * 1999-03-08 2000-09-15 Aventis Cropscience Sa Nouvelles compositions pesticides et/ou regulatrices de croissance
GB0125216D0 (en) * 2001-10-19 2001-12-12 Univ Strathclyde Dendrimers for use in targeted delivery
NO322724B1 (no) * 2004-04-15 2006-12-04 Sinvent As Fremgangsmåte til fremstilling av polyforgrenet organisk/uorganisk hybridpolymer
AU2005317193A1 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI557154B (zh) * 2015-07-02 2016-11-11 國立臺灣科技大學 超分子聚合物及其製作方法
CN113518757A (zh) * 2019-03-13 2021-10-19 伊士曼化工公司 可用于制造环十二硫的方法

Also Published As

Publication number Publication date
WO2006115547A3 (en) 2009-06-04
CA2598430C (en) 2011-10-25
EP1877103A4 (en) 2010-11-03
EP1877103A2 (en) 2008-01-16
MX2007010402A (es) 2008-01-22
WO2006115547A2 (en) 2006-11-02
CA2598430A1 (en) 2006-11-02
TWI356709B (en) 2012-01-21
EP2325236A1 (en) 2011-05-25
JP2008545621A (ja) 2008-12-18
WO2006115547A8 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
TW200801075A (en) Dendritic polymers with enhanced amplification and interior functionality
WO2006065266A3 (en) Dendritic polymers with enhanced amplification and interior functionality
Wang et al. A novel lignin/ZnO hybrid nanocomposite with excellent UV-absorption ability and its application in transparent polyurethane coating
Tang et al. Malleable, mechanically strong, and adaptive elastomers enabled by interfacial exchangeable bonds
Wang et al. In situ synthesis of flowerlike lignin/ZnO composite with excellent UV-absorption properties and its application in polyurethane
Santos et al. Polyurethane foam impregnated with lignin as a filler for the removal of crude oil from contaminated water
TW200728406A (en) Dendritic polymers with enhanced amplification and interior functionality
Yuan et al. Poly (ionic liquid) s: An update
Cusola et al. Lignin particles for multifunctional membranes, antioxidative microfiltration, patterning, and 3D structuring
Su et al. Mechanical Properties Research and Structural Characterization of Alkali Lignin/Poly (vinyl alcohol) Reaction Films.
ATE471758T1 (de) Teilchenförmige zusammensetzungen und ihre herstellung
EP3348581A1 (en) Modified cellulose fibers
CN108026337B (zh) 橡胶组合物
Koschine et al. Correlation of gas permeation and free volume in new and used high free volume thin film composite membranes
Zuo et al. Engineering styrenic blends with poly (lactic acid)
Mishra et al. Effect of peptizer on the properties of Nafion–Laponite clay nanocomposite membranes for polymer electrolyte membrane fuel cells
WO2006133528A3 (en) Composition for producing starch foam resistant to moisture and freeze-thaw cycles
Schoustra et al. Raman Spectroscopy Reveals Phase Separation in Imine-Based Covalent Adaptable Networks
Sriram et al. Recent progress in anion exchange membranes (AEMs) in water electrolysis: synthesis, physio-chemical analysis, properties, and applications
Prochukhan et al. Room temperature fabrication of macroporous lignin membranes for the scalable production of black silicon
Kettunen Cellulose nanofibrils as a functional material
Fan et al. Polyethylene film waste-derived porous nanocomposites with superior mechanical robustness and excellent UV resistance as supported substrates for the development of multifunctional materials
CN107955534A (zh) 防霉型聚氨酯改性沥青防水涂料及其制备方法
AR057390A1 (es) Polimeros dendriticos con amplificacion aumentada y funcionalidad interior
Veetil et al. End-terminated poly (urethane–urea) hybrid approach toward nanoporous/microfilament morphology

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees